Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
| ▸ | CTH | P32929 | 1/20 | 0.39 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | APEX1 | P27695 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11139095 | 1.00 | EGLN1 (0.47) | EGLN1PLA2G2ACTHTGFBR1ALDH1A1 | |
| SCHEMBL65636 | 0.91 | EGLN1 (0.54) | EGLN1PLA2G2ACTHTGFBR1ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL18139583 | 0.89 | EGLN1 (0.52) | EGLN1PLA2G2ACTHTGFBR1ALDH1A1 | |
| Acetic Acid SCHEMBL28463102 | 0.87 | EGLN1 (0.50) | EGLN1PLA2G2ACTHTGFBR1ALDH1A1 | |
| SCHEMBL4893549 | 0.84 | TGFBR1 (0.35) | EGLN1PLA2G2ATGFBR1ALDH1A1KDM4E | |
| SCHEMBL23641442 | 0.82 | TDP1 (0.37) | TGFBR1TDP1 | |
| SCHEMBL4365280 | 0.82 | MEN1 (0.36) | TGFBR1ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL8379994 | 0.81 | MCL1 (0.39) | EGLN1TGFBR1ALDH1A1FAAHKMT2A | |
| SCHEMBL10594427 | 0.79 | EGLN1 (0.52) | EGLN1PLA2G2ACTHTGFBR1ALDH1A1 | |
| SCHEMBL8376801 | 0.78 | TGFBR1 (0.35) | EGLN1TGFBR1ALDH1A1TDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114920892-A | Magnetic heterocyclic amine molecularly imprinted composite material and preparation method and application thereof | 中国烟草总公司郑州烟草研究院 | 2022-08-19 | — | — | CN | claimed |
| CN-110201178-B | Polymer functionalized modified mesoporous carbon nanoparticles and preparation and application thereof | 沈阳药科大学 | 2022-08-02 | — | — | CN | claimed |
| CN-114621393-A | Copolymer of N- (2-hydroxy) propyl methacrylamide and N-methacryloyl glycyl glycine and application thereof | 华侨大学 | 2022-06-14 | — | — | CN | claimed |
| CN-103145932-A | Long-circulating anti-tumor targeting drug carrier and preparation method thereof | CHINESE ACAD INST CHEMISTRY | 2013-06-12 | — | — | CN | claimed |
| CN-102276755-B | Photopolymerizable chitosan derivative as well as preparation method and application thereof | UNIV BEIJING CHEMICAL | 2013-04-24 | — | — | CN | claimed |
| CN-102276755-A | Photopolymerizable chitosan derivative as well as preparation method and application thereof | — | 2011-12-14 | — | — | CN | claimed |
| US-12350337-B2 | Polymeric drug delivery conjugates and methods of making and using thereof | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2025-07-08 | — | — | US | disclosed |
| EP-4045087-A1 | POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF | University of Utah Research Foundation (US) | 2022-08-24 | — | — | EP | disclosed |
| CN-114920892-A | Magnetic heterocyclic amine molecularly imprinted composite material and preparation method and application thereof | 中国烟草总公司郑州烟草研究院 | 2022-08-19 | — | — | CN | disclosed |
| US-20220249682-A1 | POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2022-08-11 | — | — | US | disclosed |
| CN-110201178-B | Polymer functionalized modified mesoporous carbon nanoparticles and preparation and application thereof | 沈阳药科大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-114621393-A | Copolymer of N- (2-hydroxy) propyl methacrylamide and N-methacryloyl glycyl glycine and application thereof | 华侨大学 | 2022-06-14 | — | — | CN | disclosed |
| CN-114621393-A | Copolymer of N- (2-hydroxy) propyl methacrylamide and N-methacryloyl glycyl glycine and application thereof | 华侨大学 | 2022-06-14 | — | — | CN | disclosed |
| US-5369142-A | Curable mixtures with acrylic acid or methacrylic acid derivatives of amino acids | THE OHIO STATE UNIVERSITY (US) | 1994-11-29 | — | — | US | disclosed |
| EP-0403638-A1 | POLYMERISABLE COMPOSITION | KODAK LIMITED (GB) | 1990-12-27 | — | — | EP | disclosed |
| WO-1990007527-A1 | POLYMERISABLE COMPOSITION | KODAK LIMITED (GB) | 1990-07-12 | — | — | WO | disclosed |
| US-4663409-A | Alpha, beta-unsaturated carbonyl modified amino acid monomer and polymers for biomedical uses | BAUSCH & LOMB INCORPORATED (US) | 1987-05-05 | — | — | US | disclosed |
| US-4396706-A | ADDITION INTERPOLYMER PARTICLES, MATTES | FUJI PHOTO FILM CO., LTD. (JP) | 1983-08-02 | — | — | US | disclosed |
| US-4192784-A | N-(TRIS(HYDROXYMETHYL)METHYL)ACRYLAMIDE OR THE METHACRYLAMIDE COPOLYMERS, BIOLOGICAL IMMOBILIZATION | MAR-PHA SOCIETE D'ETUDES ET D'EXPLOITATION DE MARQUES (FR) | 1980-03-11 | — | — | US | disclosed |
| US-4097470-A | AMINO ACID, ACRYLATE OR ACRYLAMIDE ADDITION POLYMER | CESKOSLOVENSKA AKADEMIE VED (CS) | 1978-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12350337-B2 | Polymeric drug delivery conjugates and methods of making and using thereof | PDCD1LG2, CD274, PDCD1 | EGLN1 802/4885PLA2G2A 2904/4885CTH 2730/4885 |
| US-20220249682-A1 | POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF | PDCD1LG2, CD274, PDCD1 | EGLN1 802/4885PLA2G2A 2904/4885CTH 2730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.